Full Press Release Details
Leading Independent Proxy Advisory Firm ISS Recommends BridgeBio Pharma And Eidos Therapeutics Stockholders Vote For The Proposed Merger.
BBIO
Leading Independent Proxy Advisory Firm ISS Recommends BridgeBio Pharma And Eidos Therapeutics Stockholders Vote For The Proposed Merger
Key Takeaway: Leading Independent Proxy Advisory Firm ISS Recommends BridgeBio Pharma And Eidos Therapeutics Stockholders Vote For The Proposed Merger